ATE122238T1 - Bifunktionelle antikörperkonstruktionen und verfahren zur selektiven tötung von zellbeständen. - Google Patents
Bifunktionelle antikörperkonstruktionen und verfahren zur selektiven tötung von zellbeständen.Info
- Publication number
- ATE122238T1 ATE122238T1 AT88108793T AT88108793T ATE122238T1 AT E122238 T1 ATE122238 T1 AT E122238T1 AT 88108793 T AT88108793 T AT 88108793T AT 88108793 T AT88108793 T AT 88108793T AT E122238 T1 ATE122238 T1 AT E122238T1
- Authority
- AT
- Austria
- Prior art keywords
- component
- antibody
- lymphocyte
- bifunctional
- binding
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/46—Hybrid immunoglobulins
- C07K16/468—Immunoglobulins having two or more different antigen binding sites, e.g. multifunctional antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
- A61K47/6875—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody being a hybrid immunoglobulin
- A61K47/6879—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody being a hybrid immunoglobulin the immunoglobulin having two or more different antigen-binding sites, e.g. bispecific or multispecific immunoglobulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6020587A | 1987-06-10 | 1987-06-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE122238T1 true ATE122238T1 (de) | 1995-05-15 |
Family
ID=22028021
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT88108793T ATE122238T1 (de) | 1987-06-10 | 1988-06-01 | Bifunktionelle antikörperkonstruktionen und verfahren zur selektiven tötung von zellbeständen. |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0294703B1 (de) |
JP (1) | JPS643128A (de) |
AT (1) | ATE122238T1 (de) |
DE (1) | DE3853740T2 (de) |
ES (1) | ES2073394T3 (de) |
Families Citing this family (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5869620A (en) * | 1986-09-02 | 1999-02-09 | Enzon, Inc. | Multivalent antigen-binding proteins |
JPH03503840A (ja) * | 1988-01-15 | 1991-08-29 | セントコアー,インコーポレーテッド | 異種連結抗体およびその治療的使用 |
US4925648A (en) * | 1988-07-29 | 1990-05-15 | Immunomedics, Inc. | Detection and treatment of infectious and inflammatory lesions |
US5116964A (en) * | 1989-02-23 | 1992-05-26 | Genentech, Inc. | Hybrid immunoglobulins |
US6406697B1 (en) | 1989-02-23 | 2002-06-18 | Genentech, Inc. | Hybrid immunoglobulins |
US5173293A (en) * | 1989-02-23 | 1992-12-22 | Becton Dickinson And Company | Anti-T-cell antibodies as adjuvants |
US5225538A (en) * | 1989-02-23 | 1993-07-06 | Genentech, Inc. | Lymphocyte homing receptor/immunoglobulin fusion proteins |
FR2649119A1 (fr) * | 1989-06-30 | 1991-01-04 | Centre Nat Rech Scient | Procede de pilotage de retrovirus en utilisant des complexes bifonctionnels |
WO1991003493A1 (en) * | 1989-08-29 | 1991-03-21 | The University Of Southampton | Bi-or trispecific (fab)3 or (fab)4 conjugates |
US5650150A (en) * | 1990-11-09 | 1997-07-22 | Gillies; Stephen D. | Recombinant antibody cytokine fusion proteins |
US6025165A (en) * | 1991-11-25 | 2000-02-15 | Enzon, Inc. | Methods for producing multivalent antigen-binding proteins |
WO1994012520A1 (en) * | 1992-11-20 | 1994-06-09 | Enzon, Inc. | Linker for linked fusion polypeptides |
UA40577C2 (uk) * | 1993-08-02 | 2001-08-15 | Мерк Патент Гмбх | Біспецифічна молекула, що використовується для лізису пухлинних клітин, спосіб її одержання, моноклональне антитіло (варіанти), фармацевтичний препарат, фармацевтичний набір (варіанти), спосіб видалення пухлинних клітин |
US5723125A (en) * | 1995-12-28 | 1998-03-03 | Tanox Biosystems, Inc. | Hybrid with interferon-alpha and an immunoglobulin Fc linked through a non-immunogenic peptide |
EP1037927B1 (de) | 1997-12-08 | 2004-05-19 | Lexigen Pharmaceuticals Corp. | Heterodimäre fusionsproteine zur verwendung für gezielte immuntherapie und allgemeine immunerregung |
SK782002A3 (en) | 1999-07-21 | 2003-08-05 | Lexigen Pharm Corp | FC fusion proteins for enhancing the immunogenicity of protein and peptide antigens |
DK1200479T3 (da) | 1999-08-09 | 2006-05-15 | Emd Lexigen Res Ct Corp | Multiple cytokin-antistof-komplekser |
CA2399832C (en) | 2000-02-11 | 2011-09-20 | Stephen D. Gillies | Enhancing the circulating half-life of antibody-based fusion proteins |
AU2002248571B2 (en) | 2001-03-07 | 2007-01-18 | Merck Patent Gmbh | Expression technology for proteins containing a hybrid isotype antibody moiety |
WO2002079415A2 (en) | 2001-03-30 | 2002-10-10 | Lexigen Pharmaceuticals Corp. | Reducing the immunogenicity of fusion proteins |
BR0209177A (pt) | 2001-05-03 | 2004-10-05 | Merck Patent Gmbh | Anticorpo especìfico a tumor recombinante e uso do mesmo |
EP2354791A1 (de) | 2001-12-04 | 2011-08-10 | Merck Patent GmbH | Immunocytokine mit modulierter Selektivität |
US20030149246A1 (en) * | 2002-02-01 | 2003-08-07 | Russell John C. | Macromolecular conjugates and processes for preparing the same |
US7576186B2 (en) | 2002-04-23 | 2009-08-18 | Roger Williams Hospital | Compositions and methods for stem cell delivery |
WO2004041865A2 (en) | 2002-11-08 | 2004-05-21 | Ablynx N.V. | Stabilized single domain antibodies |
AU2003286003B2 (en) | 2002-11-08 | 2011-05-26 | Ablynx N.V. | Stabilized single domain antibodies |
BRPI0317376B8 (pt) | 2002-12-17 | 2021-05-25 | Merck Patent Gmbh | proteína de fusão de anticorpo-il2 designada como hu14.18-il2, usos da mesma, vetor e composição farmacêutica |
JP2006517789A (ja) | 2003-01-10 | 2006-08-03 | アブリンクス エン.ヴェー. | 治療用ポリペプチド、その相同物、その断片、および血小板媒介凝集の調節での使用 |
ATE485307T1 (de) | 2003-11-07 | 2010-11-15 | Ablynx Nv | Camelidae schwere ketten antikörper vhhs gegen epidermalen wachstumfaktor rezeptor (egfr) und ihre verwendung |
RU2369616C2 (ru) | 2003-12-30 | 2009-10-10 | Мерк Патент Гмбх | Слитые белки il-7 |
WO2005070967A2 (en) | 2004-01-22 | 2005-08-04 | Merck Patent Gmbh | Anti-cancer antibodies with reduced complement fixation |
US7670595B2 (en) | 2004-06-28 | 2010-03-02 | Merck Patent Gmbh | Fc-interferon-beta fusion proteins |
CN103254309B (zh) | 2005-05-18 | 2017-09-26 | 埃博灵克斯股份有限公司 | 针对肿瘤坏死因子α的改进的纳米体TM |
CA2960105A1 (en) | 2005-05-20 | 2006-11-23 | Ablynx Nv | Single domain vhh antibodies against von willebrand factor |
PL1966238T3 (pl) | 2005-12-30 | 2012-09-28 | Merck Patent Gmbh | Warianty interleukiny-12p40 o polepszonej stabilności |
CN101351477B (zh) | 2005-12-30 | 2011-11-16 | 默克专利有限公司 | 具有降低的免疫原性的抗cd19抗体 |
MX2011011044A (es) | 2009-04-22 | 2011-11-04 | Merck Patent Gmbh | Proteinas de fusion de anticuerpos con sitios de enlace de receptor fc neonatal (fcrn) modificados. |
PT2491056T (pt) | 2009-10-22 | 2021-10-26 | Univ Of Twente | Vhh para aplicação na reparação de tecidos, regeneração de órgãos, substituição de órgãos e engenharia de tecidos |
WO2017134305A1 (en) | 2016-02-05 | 2017-08-10 | Orionis Biosciences Nv | Bispecific signaling agents and uses thereof |
EP3426278B1 (de) | 2016-03-07 | 2024-01-03 | Vib Vzw | Einzeldomänenantikörper gegen cd20 |
CA3023881A1 (en) | 2016-05-13 | 2017-11-16 | Orionis Biosciences Nv | Therapeutic targeting of non-cellular structures |
MX2019009255A (es) | 2017-02-06 | 2019-11-05 | Orionis Biosciences Nv | Proteínas quiméricas dirigidas y sus usos. |
MX2020008208A (es) | 2018-02-05 | 2020-11-09 | Orionis Biosciences Inc | Agentes de unión a fibroblastos y uso de estos. |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4676980A (en) * | 1985-09-23 | 1987-06-30 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Target specific cross-linked heteroantibodies |
GB8626412D0 (en) * | 1986-11-05 | 1986-12-03 | Clark M R | Antibodies |
US4882424A (en) * | 1987-05-11 | 1989-11-21 | Dana-Farber Cancer Institute, Inc. | Activation antigen |
-
1988
- 1988-06-01 EP EP88108793A patent/EP0294703B1/de not_active Expired - Lifetime
- 1988-06-01 AT AT88108793T patent/ATE122238T1/de not_active IP Right Cessation
- 1988-06-01 DE DE3853740T patent/DE3853740T2/de not_active Expired - Fee Related
- 1988-06-01 ES ES88108793T patent/ES2073394T3/es not_active Expired - Lifetime
- 1988-06-06 JP JP63137599A patent/JPS643128A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP0294703A3 (en) | 1990-06-27 |
EP0294703B1 (de) | 1995-05-10 |
DE3853740D1 (de) | 1995-06-14 |
EP0294703A2 (de) | 1988-12-14 |
ES2073394T3 (es) | 1995-08-16 |
DE3853740T2 (de) | 1995-11-09 |
JPS643128A (en) | 1989-01-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE122238T1 (de) | Bifunktionelle antikörperkonstruktionen und verfahren zur selektiven tötung von zellbeständen. | |
DE69033705T2 (de) | Hybride immunglobuline | |
DE69014474D1 (de) | Antikörper gegen TNF-Bindungsprotein I und deren F(ab)-Fragmente. | |
DE69028412D1 (de) | Verfahren zum transport von molekülen in eukaryotenzellen | |
DE3675440D1 (de) | Neue pfropfpolymerisate und deren abmischungen mit polyamiden. | |
DE3686433D1 (de) | Verfahren und geraet zum bewegen und herstellen von unterirdischen durchlaessen im boden. | |
DE68901878D1 (de) | Verfahren zur faerbung von nichtradioaktiven markierten nukleinsaeuren und zusammensetzung zum gebrauch in diesem verfahren. | |
ATA205288A (de) | Verfahren zur gemeinsamen vergasung von fluessigen und festen, staubfoermigen brennstoffen | |
PT85992A (de) | Verfahren zur bestimmung von anti-hiv, mittel dazu und ihre verwendung in diesem verfahren | |
CA2011479A1 (en) | Process for the adhesive binding of paper layers | |
ATE11224T1 (de) | Wundheilende zusammensetzungen. | |
DE58904672D1 (de) | Verfahren zur herstellung einer festphasenmatrix. | |
DE3581185D1 (de) | Neue pfropfpolymerisate und deren abmischungen mit polyamiden. | |
ATE164381T1 (de) | Polyacrylamid-matrix-gel | |
EP0374946A3 (de) | Verfahren zum Nachweis von kohlenhydrathaltigen Verbindungen | |
TR23834A (tr) | Parafin bakimindan zengin petrollerde ve petrol fraksiyonlarinda(i) akis duezelticisi olarak atilik ve/ veya metakrilik asit esterlerinin seckin...... | |
DE59001699D1 (de) | Vorrichtung zum querschneiden und querschweissen von bahnen. | |
DE58906771D1 (de) | Neue Copolymere, deren Mischungen mit Poly(meth)acrylsäureestern und deren Verwendung zur Verbesserung der Fliessfähigkeit von Rohölen in der Kälte. | |
ATA342887A (de) | Verfahren und einrichtung zur verkohlung von biomassen in zwei fluidisierungsstufen | |
DE3883696D1 (de) | Anti-Krebs-Mittel und Reagenz zur Gewinnung von Revertanten. | |
ATE42640T1 (de) | Verfahren zum immobilisieren von substanzen an kunststoffestphasen und kunststoffestphasen zur verwendung in immunosorbentassays. | |
ATE77654T1 (de) | Verfahren zur faerbung von nichtradioaktiven markierten nukleinsaeuren und zusammensetzung zum gebrauch in diesem verfahren. | |
DE3863312D1 (de) | Herstellungsverfahren von methanol und in diesem verfahren zu verwendende katalysatorzusammenstellung. | |
ATE55608T1 (de) | Mittel und verfahren zur funktionalisierung von nukleinsaeuren. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |